<b>Results:</b> We found that high <i>TFRC</i> expression correlates with significantly worse overall survival in multiple common solid tumor types, a higher tumor mutational burden (TMB), an increase in infiltrating effector cells with upregulated immune checkpoint markers within the TME, and increased frequency of specific high-risk genomic alterations. The gene discussed is TFRC; the disease is neoplasm.